Skip to content
healthcare.dev

buPropion Hydrochloride XL

NDC 72516-035, bupropion hydrochloride, tablet, extended release, from Oryza pharmaceuticals Inc..

Product NDC
72516-035
Status
Listed
Labeler
Oryza pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211200
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72516-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
72516-035-037251600350330 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-03)
72516-035-097251600350990 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-09)
72516-035-5072516003550500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/004d8121-59d4-46c4-acb8-b2dd097bf556
  • NADAC price for package 72516003550

    GET /v1/drugs/nadac/72516003550

Use it

Look up 72516-035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72516-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72516-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.